Para-Infectious Opsoclonus Myoclonus Syndrome with COVID-19

Overview

Journal Ann Indian Acad Neurol

Specialty Neurology

Date 2022 Aug 8

PMID 35936604

Authors

Jacob Chacko

Boby V Maramattom

Affiliations

Soon will be listed here.

Citing Articles

A case of suspected paraneoplastic nerve syndrome associated with prostate cancer or opsoclonus-myoclonus syndrome associated with COVID-19 infection, but symptoms improved after treatment of both.

Tomomasa N, Kayano S, Monzen T, Shimomura T, Kimura T IJU Case Rep. 2025; 8(2):129-132.

PMID: 40034919 PMC: 11872211. DOI: 10.1002/iju5.12825.

A rare case of opsoclonus myoclonus syndrome following COVID-19 illness.

Shil R, Dunai C, Seed A, Wood G, Collie C, Pendered S Clin Med (Lond). 2024; 23(Suppl 6):40.

PMID: 38182203 PMC: 11046651. DOI: 10.7861/clinmed.23-6-s40.

De Novo Movement Disorders Associated with COVID-19- A Systematic Review of Individual Patients.

Pillai K, Misra S, Siripurapu G, Aliyar A, Bhat P, Rajan R Ann Indian Acad Neurol. 2023; 26(5):702-707.

PMID: 38022478 PMC: 10666879. DOI: 10.4103/aian.aian_572_23.

Opsoclonus-Myoclonus-Ataxia Syndrome Due to Covid-19.

Adamaszek M, Langner S, Mehrholz J, Heiinrich A Cerebellum. 2023; 23(3):1245-1248.

PMID: 37814146 DOI: 10.1007/s12311-023-01610-9.

Opsoclonus Myoclonus Ataxia Syndrome Due to SARS-CoV-2.

Finsterer J, Scorza F Neuroophthalmology. 2023; 47(1):1-6.

PMID: 36798867 PMC: 9928447. DOI: 10.1080/01658107.2022.2128378.

References

Armangue T, Sabater L, Torres-Vega E, Martinez-Hernandez E, Arino H, Petit-Pedrol M . Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies. JAMA Neurol. 2016; 73(4):417-24. PMC: 5823978. DOI: 10.1001/jamaneurol.2015.4607. View

Emamikhah M, Babadi M, Mehrabani M, Jalili M, Pouranian M, Daraie P . Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature. J Neurovirol. 2021; 27(1):26-34. PMC: 7831695. DOI: 10.1007/s13365-020-00941-1. View

Mendez-Guerrero A, Laespada-Garcia M, Gomez-Grande A, Ruiz-Ortiz M, Blanco-Palmero V, Azcarate-Diaz F . Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection. Neurology. 2020; 95(15):e2109-e2118. DOI: 10.1212/WNL.0000000000010282. View

Graus F, Titulaer M, Balu R, Benseler S, Bien C, Cellucci T . A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016; 15(4):391-404. PMC: 5066574. DOI: 10.1016/S1474-4422(15)00401-9. View

Zuhorn F, Graf T, Klingebiel R, Schabitz W, Rogalewski A . Postvaccinal Encephalitis after ChAdOx1 nCov-19. Ann Neurol. 2021; 90(3):506-511. PMC: 8426979. DOI: 10.1002/ana.26182. View

Caviness J, Forsyth P, LAYTON D, McPhee T . The movement disorder of adult opsoclonus. Mov Disord. 1995; 10(1):22-7. DOI: 10.1002/mds.870100106. View

Wiegand S, Mitchell W, Santoro J . Immunotherapy responsive SARS-CoV-2 infection exacerbating opsoclonus myoclonus syndrome. Mult Scler Relat Disord. 2021; 50:102855. PMC: 7899919. DOI: 10.1016/j.msard.2021.102855. View

Oh S, Kim J, Dieterich M . Update on opsoclonus-myoclonus syndrome in adults. J Neurol. 2018; 266(6):1541-1548. DOI: 10.1007/s00415-018-9138-7. View

Maramattom B, Bhattacharjee S . Neurological Complications with COVID-19: A Contemporaneous Review. Ann Indian Acad Neurol. 2020; 23(4):468-476. PMC: 7657269. DOI: 10.4103/aian.AIAN_596_20. View

10.

Klaas J, Ahlskog J, Pittock S, Matsumoto J, Aksamit A, Bartleson J . Adult-onset opsoclonus-myoclonus syndrome. Arch Neurol. 2012; 69(12):1598-607. DOI: 10.1001/archneurol.2012.1173. View

11.

Sacchi M, Tamiazzo S, Stobbione P, Agatea L, De Gaspari P, Stecca A . SARS-CoV-2 infection as a trigger of autoimmune response. Clin Transl Sci. 2020; 14(3):898-907. PMC: 8212749. DOI: 10.1111/cts.12953. View